State of the art psychopharmacological treatment options in seasonal affective disorder

Basit Öğe Kaydı
dc.authorid0000-0002-6965-370X
dc.authorid0000-0003-0585-2184
dc.authorid0000-0003-4949-0154
dc.authorid0000-0001-7367-3351
dc.contributor.authorYıldız, Mesut
dc.contributor.authorBatmaz, Sedat
dc.contributor.authorSongur, Emrah
dc.contributor.authorOral, Esat Timuçin
dc.date.accessioned2020-11-21T15:53:28Z
dc.date.available2020-11-21T15:53:28Z
dc.date.issued2016en_US
dc.departmentİstanbul Ticaret Üniversitesi, Fen-Edebiyat Fakültesi, Psikoloji Bölümüen_US
dc.description.abstractSeasonal affective disorder (SAD) is defined as a subtype of mood disorders in DSM 5, and it is characterized by a seasonal onset. SAD is proposed to be related to the seasonal changes in naturally occurring light, and the use of bright light therapy for depressive symptoms has been shown to reduce them in placebo controlled trials. Cognitive behavioral therapy has also been demonstrated to be effective in SAD. This review article aims to focus on the psychopharmacological treatment options for SAD. According to clinical trial results, first line treatment options seem to be sertraline and fluoxetine, and are well tolerated by the patients. There is some evidence that other antidepressants (e.g. bupropion) might be effective as well. Although clinical trials have shown that some of these antidepressants may be of benefit, a recent review has concluded that there is not enough evidence to support the use of any of these agents for the treatment of SAD yet. Moreover, more studies are still needed to evaluate the effectiveness of other treatment options, e.g., propranolol, melatonin, hypericum, etc. In addition to the above proposed treatments, patients with seasonal depressive symptoms should thoroughly be evaluated for any cues of bipolarity, and their treatment should be planned accordingly. en_US
dc.identifier.citationYıldız, M., Batmaz, S., Songur, E., & Oral, E. T. (2016). State of the Art Psychopharmacological Treatment Options in Seasonal Affective Disorder. Psychiatria Danubina, 28(1), 25-29.
dc.identifier.endpage29en_US
dc.identifier.issn0353-5053
dc.identifier.issue1en_US
dc.identifier.pmid26938817en_US
dc.identifier.scopus2-s2.0-84968883813en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage25en_US
dc.identifier.urihttps://hdl.handle.net/11467/3591
dc.identifier.volume28en_US
dc.identifier.wosWOS:000381877700003
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMedicinska Naklada Zagreben_US
dc.relation.ispartofPsychiatria Danubinaen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntidepressantsen_US
dc.subjectPsychopharmacological Treatmenten_US
dc.subjectSADen_US
dc.subjectSeasonal Affective Disorderen_US
dc.titleState of the art psychopharmacological treatment options in seasonal affective disorderen_US
dc.typeReviewen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
FEF, Psikoloji Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu